These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26821015)

  • 1. Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic Mice.
    Machado V; Zöller T; Attaai A; Spittau B
    Int J Mol Sci; 2016 Jan; 17(2):. PubMed ID: 26821015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb.
    Vroon A; Drukarch B; Bol JG; Cras P; Brevé JJ; Allan SM; Relton JK; Hoogland PV; Van Dam AM
    Exp Gerontol; 2007 Aug; 42(8):762-71. PubMed ID: 17592750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.
    Pisanu A; Lecca D; Mulas G; Wardas J; Simbula G; Spiga S; Carta AR
    Neurobiol Dis; 2014 Nov; 71():280-91. PubMed ID: 25134730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease.
    Zhao Q; Gao J; Li W; Cai D
    Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
    J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic and progressive Parkinson's disease MPTP model in adult and aged mice.
    Muñoz-Manchado AB; Villadiego J; Romo-Madero S; Suárez-Luna N; Bermejo-Navas A; Rodríguez-Gómez JA; Garrido-Gil P; Labandeira-García JL; Echevarría M; López-Barneo J; Toledo-Aral JJ
    J Neurochem; 2016 Jan; 136(2):373-87. PubMed ID: 26500044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease.
    Depboylu C; Stricker S; Ghobril JP; Oertel WH; Priller J; Höglinger GU
    Exp Neurol; 2012 Dec; 238(2):183-91. PubMed ID: 22964486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Van Kampen JM; Baranowski D; Kay DG
    PLoS One; 2014; 9(5):e97032. PubMed ID: 24804730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of microglia augments the dopaminergic neurotoxicity of MPTP.
    Yang X; Ren H; Wood K; Li M; Qiu S; Shi FD; Ma C; Liu Q
    FASEB J; 2018 Jun; 32(6):3336-3345. PubMed ID: 29401614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14-3-3 inhibition promotes dopaminergic neuron loss and 14-3-3θ overexpression promotes recovery in the MPTP mouse model of Parkinson's disease.
    Ding H; Underwood R; Lavalley N; Yacoubian TA
    Neuroscience; 2015 Oct; 307():73-82. PubMed ID: 26314634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated microglia affect the nigro-striatal dopamine neurons differently in neonatal and aged mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Sawada H; Hishida R; Hirata Y; Ono K; Suzuki H; Muramatsu S; Nakano I; Nagatsu T; Sawada M
    J Neurosci Res; 2007 Jun; 85(8):1752-61. PubMed ID: 17469135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel para-phenyl substituted diindolylmethanes protect against MPTP neurotoxicity and suppress glial activation in a mouse model of Parkinson's disease.
    De Miranda BR; Popichak KA; Hammond SL; Miller JA; Safe S; Tjalkens RB
    Toxicol Sci; 2015 Feb; 143(2):360-73. PubMed ID: 25406165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor D3 expressed on CD4+ T cells favors neurodegeneration of dopaminergic neurons during Parkinson's disease.
    González H; Contreras F; Prado C; Elgueta D; Franz D; Bernales S; Pacheco R
    J Immunol; 2013 May; 190(10):5048-56. PubMed ID: 23589621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease.
    Noelker C; Stuckenholz V; Reese JP; Alvarez-Fischer D; Sankowski R; Rausch T; Oertel WH; Hartmann A; van Patten S; Al-Abed Y; Bacher M
    Neurodegener Dis; 2013; 12(2):103-10. PubMed ID: 23147695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
    McGeer PL; Schwab C; Parent A; Doudet D
    Ann Neurol; 2003 Nov; 54(5):599-604. PubMed ID: 14595649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.